Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Pages
▼
Thursday, September 19, 2013
FDA Compounding Sting Spurs Rise in Aseptic Observations in Form 483s
Poor microbial contamination control was the top Form 483 observation in the first quarter of this year, a finding linked to a slew of compounding pharmacy inspections.
This article is viewable by subscribers only. To view this article, please select an option below.
No comments:
Post a Comment